The following is a summary of the Company’s outstanding restricted common shares and changes therein for the three months ended March 31, 2026:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, 2026 |
|
|
|
Number of
Restricted
Shares |
|
|
Weighted
Average Grant
Date Fair Value |
|
Nonvested at beginning of period |
|
|
90,155 |
|
|
$ |
19.72 |
|
Granted |
|
|
51,378 |
|
|
|
24.87 |
|
Vested |
|
|
(62,527 |
) |
|
|
20.92 |
|
Forfeited |
|
|
— |
|
|
|
— |
|
Nonvested at end of period |
|
|
79,006 |
|
|
$ |
22.12 |
|
The following is a summary of the status of the Company’s outstanding restricted common shares as of March 31, 2026:
|
|
|
|
|
|
|
|
|
|
|
|
|
At March 31, 2026 |
|
Date of Award |
|
Shares |
|
|
Remaining Expense |
|
|
Remaining Vesting
Period (Years) |
|
March 3, 2022 |
|
|
1,467 |
|
|
|
27 |
|
|
|
0.75 |
|
March 14, 2023 |
|
|
4,373 |
|
|
|
87 |
|
|
|
1.75 |
|
March 12, 2024 |
|
|
10,931 |
|
|
|
158 |
|
|
|
2.75 |
|
March 12, 2024 |
|
|
2,586 |
|
|
|
28 |
|
|
|
0.75 |
|
September 9, 2024 |
|
|
858 |
|
|
|
10 |
|
|
|
1.50 |
|
March 11, 2025 |
|
|
13,002 |
|
|
|
258 |
|
|
|
3.75 |
|
March 11, 2025 |
|
|
7,269 |
|
|
|
135 |
|
|
|
1.75 |
|
March 13, 2026 |
|
|
15,317 |
|
|
|
373 |
|
|
|
5.00 |
|
March 13, 2026 |
|
|
23,203 |
|
|
|
556 |
|
|
|
3.00 |
|
|
|
|
79,006 |
|
|
|
1,632 |
|
|
|
3.16 |
|
|